Annual report
3645.TEDINET S100WLO9
Period2024-06-01 → 2025-05-31
Filed2025-08-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.1bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales |
| Revenue | ¥5.3bn | 2023-06-01 → 2024-05-31 | Cons. | Net sales |
| Revenue | ¥4.5bn | 2022-06-01 → 2023-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.7bn | 2021-06-01 → 2022-05-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.9bn | 2020-06-01 → 2021-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥99m | 2024-06-01 → 2025-05-31 | Cons. | Operating income |
| Operating income | ¥298m | 2023-06-01 → 2024-05-31 | Cons. | Operating income |
| Ordinary income | ¥135m | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥323m | 2023-06-01 → 2024-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥432m | 2022-06-01 → 2023-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥450m | 2021-06-01 → 2022-05-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥336m | 2020-06-01 → 2021-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥25m | 2024-06-01 → 2025-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥153m | 2023-06-01 → 2024-05-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥68m | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥116m | 2022-06-01 → 2023-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥380m | 2021-06-01 → 2022-05-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥130m | 2020-06-01 → 2021-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥38m | 2024-06-01 → 2025-05-31 | Cons. | Profit loss |
| Net income | ¥26m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss |
| Total assets | ¥4.1bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥4.0bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥3.5bn | at 2023-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥3.1bn | at 2022-05-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.1bn | at 2021-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.3bn | at 2025-05-31 | Cons. | Liabilities |
| Total liabilities | ¥2.1bn | at 2024-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.8bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31v | Cons. | Net assets |
| Net assets / equity | ¥1.7bn | at 2022-05-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.3bn | at 2021-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-05-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2022-05-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥869m | at 2021-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥81m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥120m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥429m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥343m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥392m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥260m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥285m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥62m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥355m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥88m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥219m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥144m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥18m | 2022-06-01 → 2023-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥282m | 2021-06-01 → 2022-05-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥34m | 2020-06-01 → 2021-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-7.64 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.66 | 2023-06-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.97 | 2022-06-01 → 2023-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.44 | 2021-06-01 → 2022-05-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.36 | 2020-06-01 → 2021-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥196.5 | at 2025-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥210.85 | at 2024-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥211.94 | at 2023-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥193.19 | at 2022-05-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥144.23 | at 2021-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 42.0% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.8% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.3% | at 2023-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2022-05-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.0% | at 2021-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | -3.8% | 2024-06-01 → 2025-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 0.3% | 2023-06-01 → 2024-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2022-06-01 → 2023-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 25.8% | 2021-06-01 → 2022-05-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.6% | 2020-06-01 → 2021-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 296 | at 2025-05-31 | Cons. | Number of employees |
| Employees | 274 | at 2024-05-31 | Cons. | Number of employees |
| Employees | 186 | at 2023-05-31v | Cons. | Number of employees |
| Employees | 163 | at 2022-05-31v | Cons. | Number of employees |
| Employees | 113 | at 2021-05-31d | Cons. | Number of employees |
| Revenue | ¥2.1bn | 2024-06-01 → 2025-05-31 | Standalone | Net sales |
| Revenue | ¥2.1bn | 2023-06-01 → 2024-05-31 | Standalone | Net sales |
| Revenue | ¥1.8bn | 2022-06-01 → 2023-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.6bn | 2021-06-01 → 2022-05-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.4bn | 2020-06-01 → 2021-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥148m | 2024-06-01 → 2025-05-31 | Standalone | Operating income |
| Operating income | ¥302m | 2023-06-01 → 2024-05-31 | Standalone | Operating income |
| Ordinary income | ¥180m | 2024-06-01 → 2025-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥183m | 2023-06-01 → 2024-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥403m | 2022-06-01 → 2023-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥352m | 2021-06-01 → 2022-05-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥322m | 2020-06-01 → 2021-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥39m | 2024-06-01 → 2025-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥177m | 2023-06-01 → 2024-05-31 | Standalone | Income before income taxes |
| Net income | −¥70m | 2024-06-01 → 2025-05-31 | Standalone | Profit loss |
| Net income | ¥81m | 2023-06-01 → 2024-05-31 | Standalone | Profit loss |
| Net income | ¥214m | 2022-06-01 → 2023-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥248m | 2021-06-01 → 2022-05-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥137m | 2020-06-01 → 2021-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.0bn | at 2025-05-31 | Standalone | Assets |
| Total assets | ¥3.1bn | at 2024-05-31 | Standalone | Assets |
| Total assets | ¥2.8bn | at 2023-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.5bn | at 2022-05-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.8bn | at 2021-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.2bn | at 2025-05-31 | Standalone | Liabilities |
| Total liabilities | ¥1.1bn | at 2024-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.8bn | at 2025-05-31 | Standalone | Net assets |
| Net assets / equity | ¥2.0bn | at 2024-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.9bn | at 2023-05-31v | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2022-05-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.3bn | at 2021-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥768m | at 2025-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2024-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-7.87 | 2024-06-01 → 2025-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.98 | 2023-06-01 → 2024-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.89 | 2022-06-01 → 2023-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.4 | 2021-06-01 → 2022-05-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.23 | 2020-06-01 → 2021-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥3 | 2024-06-01 → 2025-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2023-06-01 → 2024-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥2.5 | 2022-06-01 → 2023-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2021-06-01 → 2022-05-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2020-06-01 → 2021-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥201.8 | at 2025-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥216.43 | at 2024-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥209.76 | at 2023-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥181.56 | at 2022-05-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥148.43 | at 2021-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 58.9% | at 2025-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.9% | at 2024-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2023-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.3% | at 2022-05-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.9% | at 2021-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -3.8% | 2024-06-01 → 2025-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.2% | 2023-06-01 → 2024-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2022-06-01 → 2023-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.3% | 2021-06-01 → 2022-05-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2020-06-01 → 2021-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,773,000 | at 2025-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2024-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2023-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2022-05-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2021-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 134 | at 2025-05-31 | Standalone | Number of employees |
| Employees | 121 | at 2024-05-31 | Standalone | Number of employees |
| Employees | 114 | at 2023-05-31v | Standalone | Number of employees |
| Employees | 98 | at 2022-05-31v | Standalone | Number of employees |
| Employees | 89 | at 2021-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 100
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-06-01 → 2025-05-31 | ¥998,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-06-01 → 2025-05-31 | ¥998,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-06-01 → 2025-05-31 | ¥998,000 |
| Cloud Integrationreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥4m |
| Cloud Integrationreportable segment | employees | at 2025-05-31 | 56 pure |
| Cloud Integrationreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥375m |
| Cloud Integrationreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥375m |
| Cloud Integrationreportable segment | segment assets | at 2025-05-31 | ¥751m |
| Cloud Integrationreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥34m |
| Mediaplatformreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥2m |
| Mediaplatformreportable segment | employees | at 2025-05-31 | 30 pure |
| Mediaplatformreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥1.1bn |
| Mediaplatformreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥1.1bn |
| Mediaplatformreportable segment | segment assets | at 2025-05-31 | ¥126m |
| Mediaplatformreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥542m |
| Medical B To Breportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥1m |
| Medical B To Breportable segment | employees | at 2025-05-31 | 10 pure |
| Medical B To Breportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥158m |
| Medical B To Breportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥158m |
| Medical B To Breportable segment | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥300,000 |
| Medical B To Breportable segment | segment assets | at 2025-05-31 | ¥29m |
| Medical B To Breportable segment | segment profit | 2024-06-01 → 2025-05-31 | −¥14m |
| Medical Institution Management Supportreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥22m |
| Medical Institution Management Supportreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥19m |
| Medical Institution Management Supportreportable segment | employees | at 2025-05-31 | 172 pure |
| Medical Institution Management Supportreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥4.4bn |
| Medical Institution Management Supportreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥4.4bn |
| Medical Institution Management Supportreportable segment | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥29,000 |
| Medical Institution Management Supportreportable segment | segment assets | at 2025-05-31 | ¥1.9bn |
| Medical Institution Management Supportreportable segment | segment profit | 2024-06-01 → 2025-05-31 | ¥190m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | capex | 2024-06-01 → 2025-05-31 | ¥121m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | depreciation | 2024-06-01 → 2025-05-31 | ¥3m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | revenue | 2024-06-01 → 2025-05-31 | ¥41m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | revenue external | 2024-06-01 → 2025-05-31 | ¥41m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | segment profit | 2024-06-01 → 2025-05-31 | −¥154m |
| —segment total | capex | 2024-06-01 → 2025-05-31 | ¥143m |
| —segment total | depreciation | 2024-06-01 → 2025-05-31 | ¥29m |
| —segment total | revenue | 2024-06-01 → 2025-05-31 | ¥6.1bn |
| —segment total | revenue external | 2024-06-01 → 2025-05-31 | ¥6.1bn |
| —segment total | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥329,000 |
| —segment total | segment assets | at 2025-05-31 | ¥2.8bn |
| —segment total | segment profit | 2024-06-01 → 2025-05-31 | ¥597m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-06-01 → 2025-05-31 | ¥143m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-06-01 → 2025-05-31 | ¥29m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-06-01 → 2025-05-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-06-01 → 2025-05-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-06-01 → 2025-05-31 | ¥329,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-05-31 | ¥2.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-06-01 → 2025-05-31 | ¥598m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2024-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2024-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2024-05-31 | ¥4m |
| Cloud Integrationreportable segment | capex | 2023-06-01 → 2024-05-31 | ¥185,000 |
| Cloud Integrationreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥628,000 |
| Cloud Integrationreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥48m |
| Cloud Integrationreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥48m |
| Cloud Integrationreportable segment | segment assets | at 2024-05-31 | ¥610m |
| Cloud Integrationreportable segment | segment profit | 2023-06-01 → 2024-05-31 | −¥6m |
| Mediaplatformreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥2m |
| Mediaplatformreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥1.1bn |
| Mediaplatformreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥1.1bn |
| Mediaplatformreportable segment | segment assets | at 2024-05-31 | ¥70m |
| Mediaplatformreportable segment | segment profit | 2023-06-01 → 2024-05-31 | ¥627m |
| Medical B To Breportable segment | capex | 2023-06-01 → 2024-05-31 | ¥5m |
| Medical B To Breportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥602,000 |
| Medical B To Breportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥185m |
| Medical B To Breportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥185m |
| Medical B To Breportable segment | revenue intersegment | 2023-06-01 → 2024-05-31 | ¥9,000 |
| Medical B To Breportable segment | segment assets | at 2024-05-31 | ¥55m |
| Medical B To Breportable segment | segment profit | 2023-06-01 → 2024-05-31 | ¥20m |
| Medical Institution Management Supportreportable segment | capex | 2023-06-01 → 2024-05-31 | ¥34m |
| Medical Institution Management Supportreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥15m |
| Medical Institution Management Supportreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥3.9bn |
| Medical Institution Management Supportreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥3.9bn |
| Medical Institution Management Supportreportable segment | revenue intersegment | 2023-06-01 → 2024-05-31 | ¥101,000 |
| Medical Institution Management Supportreportable segment | segment assets | at 2024-05-31 | ¥1.6bn |
| Medical Institution Management Supportreportable segment | segment profit | 2023-06-01 → 2024-05-31 | ¥188m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | capex | 2023-06-01 → 2024-05-31 | ¥1m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | depreciation | 2023-06-01 → 2024-05-31 | ¥65,000 |
| Pre Symptomatic And Preventive Disease Platformreportable segment | revenue | 2023-06-01 → 2024-05-31 | ¥26m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | revenue external | 2023-06-01 → 2024-05-31 | ¥26m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | segment assets | at 2024-05-31 | ¥54m |
| Pre Symptomatic And Preventive Disease Platformreportable segment | segment profit | 2023-06-01 → 2024-05-31 | −¥66m |
| —segment total | capex | 2023-06-01 → 2024-05-31 | ¥41m |
| —segment total | depreciation | 2023-06-01 → 2024-05-31 | ¥18m |
| —segment total | revenue | 2023-06-01 → 2024-05-31 | ¥5.2bn |
| —segment total | revenue external | 2023-06-01 → 2024-05-31 | ¥5.2bn |
| —segment total | revenue intersegment | 2023-06-01 → 2024-05-31 | ¥111,000 |
| —segment total | segment assets | at 2024-05-31 | ¥2.4bn |
| —segment total | segment profit | 2023-06-01 → 2024-05-31 | ¥763m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-06-01 → 2024-05-31 | ¥41m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-06-01 → 2024-05-31 | ¥18m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2024-05-31 | ¥5.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2024-05-31 | ¥5.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-06-01 → 2024-05-31 | ¥111,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-05-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2024-05-31 | ¥766m |
| Mediaplatformreportable segment | employees | at 2025-05-31 | 30 pure |
| Medical B To Breportable segment | employees | at 2025-05-31 | 10 pure |
| Medical Institution Management Supportreportable segment | employees | at 2025-05-31 | 66 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,470
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 134 | |
| Average number of temporary workers | Prior4YearInstant_NonConsolidatedMember | 1 | |
| Average number of temporary workers | Prior3YearInstant_NonConsolidatedMember | 1 | |
| Average number of temporary workers | Prior2YearInstant_NonConsolidatedMember | 2 | |
| Average number of temporary workers | Prior1YearInstant_NonConsolidatedMember | 1 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 1 | |
| Total shareholder return | Prior4YearInstant_NonConsolidatedMember | 2.649 | |
| Total shareholder return | Prior3YearInstant_NonConsolidatedMember | 1.935 | |
| Total shareholder return | Prior2YearInstant_NonConsolidatedMember | 1.647 | |
| Total shareholder return | Prior1YearInstant_NonConsolidatedMember | 1.557 | |
| Total shareholder return | CurrentYearInstant_NonConsolidatedMember | 1.361 | |
| Total return on share price index | Prior4YearInstant_NonConsolidatedMember | 1.171 | |
| Total return on share price index | Prior3YearInstant_NonConsolidatedMember | 0.683 | |
| Total return on share price index | Prior2YearInstant_NonConsolidatedMember | 0.761 | |
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 0.630 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 0.759 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E24982-000MediaplatformReportableSegmentsMember | 30 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E24982-000MediaplatformReportableSegmentsMember | 1 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 172 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 1 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E24982-000MedicalBToBReportableSegmentsMember | 10 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E24982-000MedicalBToBReportableSegmentsMember | － | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E24982-000CloudIntegrationReportableSegmentsMember | 56 | |
| Average number of temporary workers | CurrentYearInstant_jpcrp030000-asr_E24982-000CloudIntegrationReportableSegmentsMember | － | |
| Number of employees | CurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | |
| Average number of temporary workers | CurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 28 | |
| Average number of temporary workers | CurrentYearInstant_CorporateSharedMember | － | |
| Number of employees | CurrentYearInstant | 296 | |
| Average number of temporary workers | CurrentYearInstant | 2 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 134 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 1 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 36.3 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 4.9 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 5231000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E24982-000MediaplatformReportableSegmentsMember | 30 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E24982-000MediaplatformReportableSegmentsMember | 1 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | 66 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E24982-000MedicalInstitutionManagementSupportReportableSegmentsMember | － | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E24982-000MedicalBToBReportableSegmentsMember | 10 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E24982-000MedicalBToBReportableSegmentsMember | － | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 28 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | － | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 134 | |
| Average number of temporary workers | CurrentYearInstant_NonConsolidatedMember | 1 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | 48.5 | |
| Performance description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row2Member | 27.1 | |
| Research and development expenses research and development activities | CurrentYearDuration_ReportableSegmentsMember | 23880000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10773000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 10773000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |